Atlas market file · Equity · United States
Harte Hanks IncHHS
- Last close
- 2.28
- Change
- +0.88%
- 96-bar range
- 2 – 3.25
- As of
- 6 Aug 2026
Harte Hanks Inc is a services-direct mail advertising services issuer listed as HHS on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-69.76% over the window).
Source rail: Yahoo Finance chart API (HHS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for HHS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
HHS public profile
Services-direct mail advertising services issuer. Harte Hanks Inc is connected to current market context, cited company sources and its retained research file.
Harte Hanks Inc trades as HHS on NASDAQ. Harte Hanks Inc (HHS) has a latest verified close of 2.28, up 0.88%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files HHS under USA Stocks for browsing.
What changed for Harte Hanks Inc today
Harte Hanks Inc, the NASDAQ-listed customer experience company, reported $37.3 million of revenue for the quarter ended 31 March 2026 but still produced a net loss of $628,000 and negative operating income of $768,000, while burning $575,000 of operating cash. Diluted EPS was minus $0.08 on 7.4 million diluted shares. The balance sheet still shows $4.5 million in cash and $90.4 million of assets against $70.3 million of liabilities, leaving $20.1 million of equity that looks more like a temporary ledger balance than a durable cushion.
The company describes itself as a ‘leading global customer experience company’ whose customer care services handle over seven billion inquiries a year for global brands. Its product pages promise ‘seamless support solutions’ and ‘contact centre as a service’, complete with glossy benchmarks and customer-centric language. Yet the same quarter saw its Fulfillment & Logistics Services segment lose $3.3 million of revenue-16.6% year-over-year-while its Revenue Solutions segment fell 9.9%, eroding $0.9 million. The human upgrade is David Fisher’s appointment as President, charged with driving ‘client innovation and growth’, but the revenue ledger is the part that does not lie.
Filed facts: revenue of $37.3 million, net loss of $628,000, operating loss of $768,000, and operating cash burn of $575,000 for the quarter ended 31 March 2026. Diluted EPS was minus $0.08 on 7.4 million diluted shares. Assets stood at $90.4 million with $70.3 million of liabilities and $20.1 million of equity; cash and equivalents were $4.5 million. Capital expenditures were $347,000 in the quarter. The company’s DEF 14A describes a ‘significant transformation’ in recent years, while the 10-Q records the revenue contraction and cash haemorrhage.
For those who like to anchor to charts, the NASDAQ-listed share price can be tracked via the standard TradingView route for HHS. The symbol is live on NASDAQ and the company’s EDGAR index carries the full filing trail, but the price action is not the story here; the story is the gap between the customer-experience narrative and the filed quarterly ledger.
What changed this week: the 10-Q for Q1 2026 was filed on 15 May 2026, confirming the revenue and income trajectory. The company’s May 2026 8-Ks and late-June Form 4 filings show routine insider activity, but nothing that alters the core cash and revenue trend. The DEF 14A filed on 9 April 2026 frames the board’s view of a transformation, while the 10-Q shows the transformation is still a work in progress. No dividend, no buybacks, and no fresh credit lines are visible in the filings; the company is funding operations out of existing cash and modest capex.
The outstanding question is whether the appointment of David Fisher as President signals an inflection point. The filings do not yet show a plan, a segment rebound, or cash-flow recovery, so the board’s story must be judged against future quarterly filings rather than today’s ledger. Until then, the company remains a customer-experience narrative with a cash-burn reality.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
HHS technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on HHS
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep HHS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
HHS FAQ
What is Harte Hanks Inc (HHS)?Harte Hanks Inc (HHS) has a latest verified close of 2.28, up 0.88%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Harte Hanks Inc (HHS) has a latest verified close of 2.28, up 0.88%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for HHS?Harte Hanks Inc (HHS) has a latest verified close of 2.28, up 0.88%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Harte Hanks Inc (HHS) has a latest verified close of 2.28, up 0.88%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files HHS under USA Stocks for browsing.
How often is the HHS page updated?The HHS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The HHS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for HHS?The HHS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:HHS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The HHS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:HHS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on HHS?Yes. The workstation can open HHS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open HHS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this HHS page investment advice?No. The HHS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The HHS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
HHS
Equity · evidence first